跳至主要内容
临床试验/NCT05935059
NCT05935059已完成不适用

Evaluation of the Efficacy of Perioperative Administration of Tianeptine Versus Pregabalin on Acute and Chronic Post Mastectomy Pain After Breast Cancer Surgery. A Double-Blinded Randomized Controlled Trial.

National Cancer Institute, Egypt1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2023年6月21日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
90
试验地点
1
主要终点
the percentage of patients who developed Post Mastectomy Pain Syndrome (PMPS)

研究概览

简要总结

Breast cancer is the most common malignancy among females. Nearly 40% of breast surgery patients experience moderate to severe acute postoperative pain, with severe pain persisting for more than 6 months in almost 20-50% of patients (post mastectomy pain syndrome) which is defined according to International Association for the Study of Pain (IASP) as pain which persists more than 3 months after mastectomy/lumpectomy affecting the anterior thorax, axilla, and/or medial upper arm. Different pharmacological tools have been in use for either prevention or treatment of such refractory pain syndrome with variable efficacy. The aim of this study is to assess the efficacy of the perioperative use of Pregabalin versus Tianeptine on the emergence of PMPS in female patients undergoing MRM for breast cancer.

详细描述

Breast cancer is the most common diagnosed malignancy among females and the 5th cause of cancer-related deaths with an estimated number of 2.3 million new cases and 685,000 deaths worldwide in 2020.

Different modalities are used for management of breast cancer including surgery, radiation therapy (RT), chemotherapy (CT), endocrine (hormone) therapy (ET), and targeted therapy. Modified Radical Mastectomy (MRM) is one of the main modalities of breast cancer treatment. It accounts for 31% of all breast surgeries. It has been reported that 40% of the females complain from moderate-to-severe pain in the immediate post-operative period after breast cancer surgery.

Acute post-mastectomy pain can cause adverse impacts on the patients as delayed discharge from post-operative recovery area, impairs pulmonary and immune functions, increases risk of ileus, thromboembolism, myocardial infarction and may lead to increased length of hospital stay. It is also an important factor leading to the development of chronic post mastectomy pain syndrome (PMPS) in almost half of the patients.

The International Association for the Study of Pain (IASP) defines PMPS as pain which persists more than 3 months after mastectomy that affects the anterior thorax, axilla, and/or medial upper arm. It is usually described as the feeling of burning, stabbing, and pulling around the treatment side. The underlying pathophysiology of PMPS is highly complicated and involves both peripheral and central sensitization. It results from injury to the peripheral nerves in the axilla or the chest wall during the dissection of axillary lymph nodes. Multiple risk factors are involved in the development of PMPS including acute postoperative pain, age < 40 years, increased BMI , diagnosis at later-stage disease, psychosocial factors (i.e., anxiety, depression, sleep disturbances, catastrophizing), preoperative pain and adjuvant therapy (chemotherapy, radiation therapy).(8)Because PMP involves issues associated not only with pain management, but also with psychosocial disruption, the assessment of each of these domains should be addressed routinely so as to enable early detection and treatment.

Different pharmacological tools have been in use for either prevention or treatment of such refractory pain syndrome with variable efficacy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Breast cancer female patients.
  • ASA class II and III.
  • Age ≥ 18 and ≤ 60 Years.
  • Body mass index (BMI): > 20 kg/m2 and < 35 kg/m
  • Type of surgery; elective breast cancer surgery (either modified radical mastectomy or conservative breast surgery) combined with axillary dissection.

排除标准

  • Patient refusal.
  • Age <18 years or >65 years.
  • BMI <20 kg/m2 and >35 kg/m
  • Known sensitivity or contraindication to drugs used in the study (Pregabalin , Tianeptine , NSAIDs, or morphine ).
  • History of psychiatric disorders or history of major depression.
  • History of chronic pain that necessitates morphine at a daily dose of 30 mg or more (or equivalent opioids).
  • history of gapabentenoids or antidepressant intake in the preceding three months.
  • Major medical conditions.
  • Pregnancy or lactation.

研究组 & 干预措施

pregabalin group (group P)

Active Comparator

pregabalin group (group P) patients will receive pregabalin (Lyrica, Pfizer, NY) 50 mg with a sip of water one hour before induction of anesthesia and repeated every 8 hours for five days after surgery. The pregabalin capsules will be given to patients by nurses blinded to the study. Neither the researcher allocating the participants, nor the assessing person knew the decoding of the groups in its relation to the allocation sequence. Data will be collected by a junior pain resident blinded to the study protocol.

干预措施: Pregabalin (Drug)

Tianeptine group (group T)

Active Comparator

Tianeptine group (group T) patients will receive Tianeptine 12.5 mg (Stablon, Servier, France)with a sip of water one hour before induction of anesthesia and repeated every 8 hours for five days after surgery. The Tianeptine capsules will be given to patients by nurses blinded to the study. Neither the researcher allocating the participants, nor the assessing person knew the decoding of the groups in its relation to the allocation sequence. Data will be collected by a junior pain resident blinded to the study protocol.

干预措施: Tianeptine (Drug)

结局指标

主要结局

the percentage of patients who developed Post Mastectomy Pain Syndrome (PMPS)

时间窗: 6 months

The Percentage of patients developing Post Mastectomy Pain Syndrome (PMPS)

次要结局

  • Changes and stability in Mean Arterial Blood Pressure (MAP)(every 15 minutes during the surgery then at 1, 2, 4, 8, 12, 16, 20 and 24 hours postoperatively)
  • Changes and stability in Heart Rate (HR)(every 15 minutes during the surgery then at 1, 2, 4, 8, 12, 16, 20 and 24 hours postoperatively)
  • Total amount of fentanyl consumed intraoperative(Time of surgery)
  • 1st time opioids requested post-operative.(24 hours after the surgery)
  • Total amount of morphine consumed postoperatively(24 hours after the surgery)
  • The degree of postoperative sedation according to Ramsay scores.(24 hours)
  • Postoperative nausea and vomiting (PONV).(24 hours)
  • Severity of PMPS according to Grading system for neuropathic pain (GSNP)(6 motnths)

研究者

发起方
National Cancer Institute, Egypt
申办方类型
Other
责任方
Principal Investigator
主要研究者

Ayman Sharawy Abdel Rahman Aboul Nasr

Principal investigator

National Cancer Institute, Egypt

研究点 (1)

Loading locations...

相似试验